Jia-feng Chen

China State Key Laboratory For Quality Ensurance And Sustainable Use Of Dao Di Herbs
Beijing, 100700, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinoma.

Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinoma.

Journal: Experimental hematology & oncology

Published: July 23, 2025

Origin authentication of Bajitian based on herbal documents and local chronicles

Origin authentication of Bajitian based on herbal documents and local chronicles

Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica

Published: July 21, 2025

Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.

Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinoma.

Journal: Science advances

Published: May 02, 2025

Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation.

Inhibition of SIRT1 relieves hepatocarcinogenesis via alleviating autophagy and inflammation.

Journal: International journal of biological macromolecules

Published: April 22, 2024

Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.

Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration.

Journal: Cellular oncology (Dordrecht, Netherlands)

Published: March 05, 2024

Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.

Autophagy suppression facilitates macrophage M2 polarization via increased instability of NF-κB pathway in hepatocellular carcinoma.

Journal: International immunopharmacology

Published: February 10, 2023

Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment.

Inhibition of autophagy in macrophage promotes IL-1β-mediated hepatocellular carcinoma progression via inflammasome accumulation and self-recruitment.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 08, 2023

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.

Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation.

Journal: Hepatology international

Published: December 02, 2022

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges.

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges.

Journal: Journal of oncology

Published: July 31, 2022

KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma.

KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma.

Journal: Cancer cell international

Published: November 24, 2021

Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis.

Laparoscopic vs. Open Repeat Hepatectomy for Recurrent Liver Tumors: A Propensity Score-Matched Study and Meta-Analysis.

Journal: Frontiers in oncology

Published: December 28, 2020

Cobalt/Bisoxazolinephosphine-Catalyzed Asymmetric Alkynylation of Isatins.

Cobalt/Bisoxazolinephosphine-Catalyzed Asymmetric Alkynylation of Isatins.

Journal: Organic letters

Published: May 29, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026